Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Robotic Surgery Offers Patients "Tremendous Benefit”

By HospiMedica International staff writers
Posted on 25 Jan 2011
Robot-assisted surgery dramatically improves outcomes in patients with uterine, endometrial, and cervical cancer, according to a new series of studies. More...


Researchers at the Jewish General Hospital (JGH; Montreal, Canada) reported the results of prospective evaluation of perioperative data and a postoperative quality-of-life survey in their experience with robotic surgeries, concluding that even in the early phases of implementation of a robotic surgical program for endometrial cancer, the procedure seems safe and confers an excellent quality of life for elderly patients. As a result, surgeons at JGH went from performing minimally invasive surgery (MIS) via laparoscopy on only 15% of endometrial cancer patients to performing robotic surgery on 95% of the patients. Cervical cancer patients who did not enjoy MIS at all are now being treated by robotic surgery in all cases. The researchers also discovered that the rate of complications and outcomes between elderly and younger patients virtually disappeared when they underwent robotic surgery.

A cost analysis that compared open radical hysterectomy with a robotic radical hysterectomy calculated that the average cost of the traditional surgical method was CAD 11,764, including hospital accommodation, the fees for the surgeon and anesthetist, medications, and other expenses. By comparison, the robot-assisted procedure cost an average of CAD 9,613, including the amortization expense of the expensive equipment. The researchers calculated that if the robot were used on a high-volume basis, the average cost per surgery would drop to CAD 8,898. The series of studies were published between October 2010 and January 2011 in the Journal of Robotic Surgery and the International Journal of Gynecological Cancer.

"Robotic surgery definitely benefits patients and society,” said lead author Walter Gotlieb, MD, head of gynecologic oncology at the JGH Segal Cancer Center. "Patient quality of life is dramatically improved, their hospital stays are much shorter, and they use far less narcotic pain medication. The majority of our patients need nothing stronger than Tylenol.”

Robotic surgery is usually safer and cheaper than open surgery, as robotic hands are steadier than human hands, possess more freedom of movement (7 degrees) than a human arm (4 degrees), thus enabling the surgeon to operate with greater flexibility. The surgeon also has greater control during MIS involving laparoscopic insertions of fiberoptic camera scopes and surgical instruments.

Related Links:

Jewish General Hospital




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.